RCEL NASDAQ
Avita Medical Inc.
1W: +15.5%
1M: +28.2%
3M: +229.3%
YTD: +337.5%
1Y: +277.6%
3Y: +50.9%
5Y: -11.0%
$16.08
+0.90 (+5.93%)
After Hours: $14.16 (-1.92, -11.97%)
Weekly Expected Move ±7.3%
$13
$14
$16
$17
$18
Credit Risk of going bust: higher than 80% of companies Debt: 11.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.59 (down 96%), Avita Medical Inc. would be worth roughly what it owes.
Total debt $48.5M against a stock market value of $377.1M.
Distance to default 2.57 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $47.6M (short-term plus half of long-term), stock volatility 84.5%; Altman Z -11.54. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.59 (down 96%), Avita Medical Inc. would be worth roughly what it owes.
Total debt $48.5M against a stock market value of $377.1M.
Distance to default 2.57 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $47.6M (short-term plus half of long-term), stock volatility 84.5%; Altman Z -11.54. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (37)
Defensive rotation: Quality over sector labels in healthcare, banks, and consumer staples
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Rating of “Moderate Buy” from Analysts
What's next for personalized mRNA cancer vaccines?
Beyond GLP-1 injectables, who wins the next phase for obesity drugs?
NewEdge Advisors LLC Purchases 62,046 Shares of Avita Medical Inc. $RCEL
Small-cap stocks with strong momentum grades and triple-digit YTD gains
564,952 Shares in Avita Medical Inc. $RCEL Bought by BlackRock Inc.
Quant Check: Top- and bottom-rated small-cap healthcare stocks post-earnings
All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy
Biotech Breakout: What's in focus after Moderna's cancer win?
Avita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy?
AVITA rises as wound care product succeeds in U.S. burn center trial
AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of “Hold” from Brokerages
Avita Medical (RCEL) Upgraded to Buy: Here's Why
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
AVITA Medical to Host Investor Webinar Briefing
Avita (RCEL) Q1 2026 Earnings Call Transcript
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript
12 Health Care Stocks Moving In Thursday's After-Market Session
AVITA Medical appoints Cary Vance as permanent CEO
AVITA Medical Names Cary Vance as Chief Executive Officer
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
AVITA Medical to Announce First Quarter 2026 Financial Results
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc. - RCEL
AVITA Medical wins BARDA contract worth up to $25.5M
12 Health Care Stocks Moving In Wednesday's After-Market Session
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade
AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
Avita Medical: Set Up For A Turnaround
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
AVITA Medical, Inc. (RCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
AVITA Medical Announces Changes to its Board of Directors
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference